Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Bionano Genomics, Inc | nt10007734x2_ex5-1.htm |
| EX-4.17 - EXHIBIT 4.17 - Bionano Genomics, Inc | nt10007734x2_ex4-17.htm |
| EX-4.16 - EXHIBIT 4.16 - Bionano Genomics, Inc | nt10007734x2_ex4-16.htm |
| EX-1.1 - EXHIBIT 1.1 - Bionano Genomics, Inc | nt10007734x2_ex1-1.htm |
| S-1/A - Bionano Genomics, Inc | nt10007734x2_s1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No. 1 to Registration Statement No. 333-237074 on Form S-1 of our report dated March 10, 2020,
relating to the financial statements of Bionano Genomics, Inc. appearing in the Annual Report on Form 10-K of Bionano Genomics, Inc. for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
San Diego, California
March 24, 2020